Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3500 of 3546 entries
View as:

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02006589 Org: User:
Start: 12/11/13 End: 01/22/14 Due: 01/22/15

Skin Irritation Study of GSK2894512 Cream

Phase: N/A Priority: Normal
NCT ID: NCT02637206 Org: User:
Start: 10/27/15 End: 12/02/15 Due: 12/02/16

WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT01681979 Org: User:
Start: 07/31/12 End: 08/31/13 Due: 08/31/14

A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04964050 Org: User:
Start: 04/21/22 End: 05/26/22 Due: 05/26/23

A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy

Phase: N/A Priority: Normal
NCT ID: NCT02798952 Org: User:
Start: 08/23/16 End: 07/05/17 Due: 07/05/18

Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02367651 Org: User:
Start: 06/30/15 End: 05/31/18 Due: 05/31/19

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

Phase: N/A Priority: Normal
NCT ID: NCT01691482 Org: User:
Start: 07/23/12 End: 10/22/12 Due: 10/22/13

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.

Phase: N/A Priority: Normal
NCT ID: NCT00197067 Org: User:
Start: 03/15/04 End: 04/26/05 Due: 04/26/06

An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine

Phase: N/A Priority: Normal
NCT ID: NCT00319137 Org: User:
Start: 12/31/05 End: - Due: -

A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females

Phase: N/A Priority: Normal
NCT ID: NCT00549900 Org: User:
Start: 12/02/07 End: 07/12/08 Due: 07/12/09

Safety and Efficacy Study in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00896363 Org: User:
Start: 04/23/09 End: 02/09/10 Due: 02/09/11

A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02446418 Org: User:
Start: 07/09/15 End: 07/20/17 Due: 07/20/18

A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01920568 Org: User:
Start: 08/31/13 End: 04/30/16 Due: 04/30/17

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00316693 Org: User:
Start: 04/26/06 End: 02/10/09 Due: 02/10/10

Post Market Surveillance for Infanrix™

Phase: N/A Priority: Normal
NCT ID: NCT00908115 Org: User:
Start: 08/01/03 End: 06/23/08 Due: 06/23/09

A Study to Evaluate GSK1325760A - a Long-Term Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT00554619 Org: User:
Start: 02/29/08 End: 01/31/11 Due: 01/31/12

Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

Phase: N/A Priority: Normal
NCT ID: NCT00871117 Org: User:
Start: 03/31/09 End: 06/15/10 Due: 06/15/11

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT05371080 Org: User:
Start: 08/10/22 End: 08/23/27 Due: 08/23/28

Long Term Special Drug Use Investigation of Mepolizumab

Phase: N/A Priority: Normal
NCT ID: NCT03028480 Org: User:
Start: 01/11/17 End: 11/22/23 Due: 11/22/24

Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00596245 Org: User:
Start: 10/31/07 End: 12/31/07 Due: 12/31/08

Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison

Phase: N/A Priority: Normal
NCT ID: NCT02076269 Org: User:
Start: 09/30/13 End: 02/28/14 Due: 02/28/15

A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848

Phase: N/A Priority: Normal
NCT ID: NCT00743860 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01494636 Org: User:
Start: 10/17/11 End: 03/15/12 Due: 03/15/13

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

Phase: N/A Priority: Normal
NCT ID: NCT05298254 Org: User:
Start: 03/07/22 End: 07/10/25 Due: 07/10/26

Study to Evaluate Handling Errors in Usage of SERETIDE® Metered Dose Inhaler (MDI) (EVOHALER®) by Adult Subjects Currently Using the SERETIDE DISKUS® Inhaler

Phase: N/A Priority: Normal
NCT ID: NCT02416180 Org: User:
Start: 06/18/15 End: 08/20/15 Due: 08/20/16